Le Lézard

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

1 2 3 4 5 6 7 8 9 10

Aujourd'hui

16:45
Jazz Pharmaceuticals plc announced today that data from the pivotal Phase 3 study of Vyxeos® (daunorubicin and cytarabine) liposome for injection compared to standard of care cytarabine and daunorubicin (7+3) were published online in the Journal of...

14:47
Shanghai Green Valley Pharmaceutical Co., Ltd. (Green Valley) a annoncé aujourd'hui que son étude de phase 3 d'administration de capsules d'oligomannurarate de sodium (GV-971) à des patients atteints légèrement à modérément de la maladie d'Alzheimer...

14:15
Alopexx Vaccine LLC today announced the publication of positive data for a veterinary vaccine demonstrating 91% protective efficacy in horse foals born to mares immunized in the last 3-6 weeks of pregnancy with its poly-N-acetyl glucosamine...

10:54
Alligator Bioscience , a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, today announced that the company has submitted a clinical trial authorization (CTA) application to the relevant regulatory...

10:20
Scientists at the University of Birmingham, UK, are one step closer to developing an eye drop that could revolutionise treatment for age-related macular degeneration (AMD).        (Photo:...

09:08
Precision BioLogic today unveiled data from a study using a new kit for a Modified Nijmegen-Bethesda Assay (MNBA) at the International Society on Thrombosis and Haemostasis' Scientific and Standardization Committee (SSC) meeting in Dublin....

08:30
Aevi Genomic Medicine, Inc. (the Company) today announced that it received positive feedback from the United States Food and Drug Administration (FDA) on an improved version of the Company's lead development molecule, AEVI-001, identified as...

08:30
Norgine B.V. today announced that results from the PLENVU® Phase III MORA trial were published in ENDOSCOPY, a monthly peer-reviewed medical journal on behalf of the European Society of Gastrointestinal Endoscopy.      (Logo:...

08:00
GT Biopharma Inc. (GTBP) and (Euronext Paris: GTBP.PA) announced today a Material Transfer Agreement (MTA) between a Major Pharmaceutical Company and Dr. Daniel Vallera, Director, Section of Molecular Cancer Therapeutics at the Masonic Cancer Center,...

08:00
Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies, congratulates Cara Therapeutics on the successful initiation of its Phase 2 clinical trial of Oral KORSUVAtm...

08:00
CARMELINA® (CArdiovascular safety and Renal Microvascular outcomE with LINAgliptin in patients with type 2 diabetes at high vascular risk) met its primary endpoint, defined as time to first occurrence of cardiovascular death, non-fatal myocardial...

08:00
Allergan plc, , a leading global pharmaceutical company and Molecular Partners (SIX: MOLN), a clinical-stage biopharmaceutical company developing a new class of drugs known as DARPin® therapies, today announced the release of two positive clinical...

06:15
In the news release, Innovative Alzheimer's Treatment from China Concludes Phase 3 Clinical Trials, issued 19-Jul-2018 by Shanghai Green Valley Pharmaceutical Co., Ltd over PR Newswire, we are advised by the company that the second sentence should...

06:00
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today issued an update letter from its President and...

02:33
Shanghai Green Valley Pharmaceutical Co., Ltd. (Green Valley) today announced that its Phase 3 Study of Sodium Oligomannurarate (GV-971) Capsules on mild-to-moderate Alzheimer's disease met its primary endpoint. This randomized, double-blinded and...


18 juillet 2018

17:05
BioArctic AB (publ) . As previously announced, the BAN2401 Phase 2b clinical study results will be presented in an oral session at the 2018 Alzheimer's Association International Conference (AAIC) on July 25, 2018 at 3:30 p.m. CDT in Chicago, IL, as...

14:27
Vapotherm, Inc. today announced the publication of a key prospective, multi-center randomized controlled trial.  The study demonstrates the non-inferiority of High Velocity Nasal Insufflation (HVNI) to traditional Non-invasive Positive Pressure...

13:03
Avella Specialty Pharmacy has just published new data showing that automated patient engagement, in combination with patient monitoring and trigger-based pharmacist interventions, have a significant impact on patient adherence and persistence....

09:00
Takara Bio USA, Inc., (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., is proud to announce that patent JP6336080B?covering the Smart-seq2 method, developed by Rickard Sandberg and exclusively licensed to...

08:45
CSSi, a global full-service patient recruitment company, today announced that its MyClinicalTrial ID (MCT ID) database has expanded to over one million patients. MCT ID was developed to improve the investigator site selection and patient recruitment...

08:15
MarketNewsUpdates.com News Commentary  Big Pharma and pioneering Biotech firms are forging ahead with Clinical Trials for identifying advanced therapies and treatments as a result of cancer having a major and continued impact on society in the...

08:05
SCYNEXIS, Inc. , a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced that the World Health Organization's (WHO) International Non-proprietary Name (INN) group has...

08:00
Evolve BioSystems, Inc. (www.evolvebiosystems.com) announced publication of a study showing that two weeks of supplementation with Bifidobacterium longum subsp. infantis EVC001 (B. infantis EVC001, currently available to consumers as Evivo® baby...

08:00
Vyriad Inc., a clinical-stage, privately held biotechnology company focused on the development of powerful first-in class oncolytic virotherapies, is pleased to announce a collaboration agreement with Merck KGaA, Darmstadt, Germany, and Pfizer to...

08:00
PainReform Ltd, developer of a proprietary reformulation technology, has received FDA approval to conduct two pivotal Phase III clinical trials for post-operative pain relief in soft and hard tissue. "This green light from the FDA enables us to...

08:00
Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announces today that 13 posters and presentations from its robust Alzheimer's disease pipeline, including the Phase 2 clinical study (Study 201) of the anti-amyloid beta (A?)...

07:00
Compugen Ltd. , a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced today that the Company will release its second quarter 2018 financial results on Wednesday, August 1, 2018 before the U.S. financial...

07:00
CTI BioPharma Corp. today announced that it recently conducted a Type B meeting with the U.S. Food and Drug Administration (FDA) for its lead product candidate pacritinib. The purpose of the meeting was to discuss the regulatory pathway for...


17 juillet 2018

13:37
Researchers have long known that stress during pregnancy may be transferred from the mother to her offspring. Many studies have shown that this stress can have long-lasting impacts on the physical and emotional health of the offspring. However, the...

13:25
TAMPA, Fla., July 17, 2018 /PRNewswire-PRWeb/ -- Florida Hospital Pepin Heart Institute is the only hospital in Tampa Bay and one of only two hospitals in Florida, now enrolling patients who have unsuccessfully tried to control high blood pressure...

12:01
CoNextions Inc. (www.conextionsmed.com) announced today that its has enrolled its first two patients in a multicenter, blinded, randomized clinical trial  comparing the CoNextions TR System to standard of care suture repair for repair of Zone 2...

11:00
The aim of tissue engineering and regenerative medicine is to create living biological tissue that can repair and replace damaged tissues in the body, something that cannot be achieved by medicine and medical procedures. In May 2018, a group of...

09:00
Eisai Inc. announced positive topline results from the CAMELLIA-TIMI 61 cardiovascular outcome trial. This 12,000 patient study of BELVIQ® (lorcaserin HCl) CIV 10 mg twice-daily was conducted at over 400 sites in eight countries including the United...

09:00
Pulmatrix, Inc. announced today that all dosing and follow up visits have been completed for Part 3 of the ongoing first-in-human study of Pulmazole (PUR1900) - an inhaled iSPERSETM formulation of the anti-fungal drug itraconazole for the treatment...

08:30
Therapix Biosciences Ltd. , a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today positive results in its pre-clinical studies evaluating THX-160, a novel pharmaceutical CB2...

08:21
RDD Pharma, a specialty pharmaceutical company focused on the development of innovative therapies for anorectal and gastrointestinal disorders, announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug...

08:00
SOM Biotech, a clinical-stage biopharmaceutical company that discovers and develops drugs for orphan indications in the Central Nervous System, has announced today the successful initiation of Phase 2a clinical trial of its repurposed compound...

08:00
OncoSec Medical Incorporated (OncoSec) , a company developing intratumoral cancer immunotherapies, today announced that Sharron Gargosky, PhD, Chief Clinical and Regulatory Officer, presented a clinical update of the Company's intratumoral therapy,...

07:05
Viking Therapeutics, Inc. ("Viking") , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the results from the company's Phase 2 study of VK5211 in...

06:00
BAROnova, Inc., announced today that it has submitted a Pre-Market Approval (PMA) application for the TransPyloric Shuttle device intended for the treatment of obesity to the Food and Drug Administration (FDA). Obesity is a worldwide epidemic with...

03:30
SQN Clinical launches SQN Health Analytics, providing clinical professionals with a clear picture of the entire trial process and all collected data, whenever and wherever they need it.        (Photo:...

03:30
SQN Clinical lance SQN Health Analytics, offrant ainsi aux professionnels médicaux la possibilité d'accéder à une vue d'ensemble claire de la totalité d'une procédure d'essai clinique et des données récoltées, quand et où ils le souhaitent.  ...


16 juillet 2018

16:15
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Phase 3 CREDENCE (Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation) clinical trial, evaluating the efficacy and safety of...

15:54
OD-OS, the global leader in the development and commercialization of navigated retinal laser systems, has achieved the revocation of the MicroPulsetm Patent (Patent no EP1856774) by Iridex Cooperation in oral proceedings at the European Patent office...

13:01
Longevity Biotech, Inc. (LBT) is launching a new clinical study to identify specific immune and inflammatory markers that could potentially be used to both diagnose Parkinson's disease (PD) and stratify patients by stage of disease. The clinical...

09:25
RegeneRx Biopharmaceuticals, Inc. ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that a new study was published comparing RGN-259 with currently...

08:30
Neurotrope Inc.  a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer's disease (AD), is announcing that the first patient has been enrolled into its confirmatory Phase 2 clinical...

07:00
MaxCyte announced that it has received Investigational New Drug (IND) clearance from the US Food and Drug Administration (FDA) to begin a clinical study in the United States with its first wholly-owned chimeric antigen receptor (CAR) therapeutic...

06:05
NeuroTrauma Sciences, LLC (NTS), a biopharmaceutical company, and Henry Ford Health System, a non-profit organization, today announce that a newly-formed subsidiary of NTS has entered into multi-year Sponsored Research and License Agreements. The new...

05:00
Peptron Inc. (087010:KS), a Korean-based public pharmaceutical company that focuses on peptide engineering and developing sustained-release medicine technology, announced today publication of preclinical data from a team of international scientists...

1 2 3 4 5 6 7 8 9 10